ORTHOPEDIATRICS CORP·4

Jun 10, 9:49 AM ET

Throdahl Mark C 4

Research Summary

AI-generated summary

Updated

Orthopediatrics (KIDS) Director Mark Throdahl Receives Award

What Happened
Mark C. Throdahl, a director of Orthopediatrics Corp. (KIDS), was granted 11,436 shares on 2026-06-09 as an award/acquisition (transaction code A). The grant is reported at $0.00 per share (total reported value $0), consistent with a restricted stock award rather than a market purchase.

Key Details

  • Transaction date: 2026-06-09; Form 4 filed: 2026-06-10 (timely filing).
  • Price: $0.00 per share; total reported value $0.
  • Shares involved: 11,436 shares granted.
  • Shares owned after transaction: Not disclosed in the provided excerpt.
  • Footnote: F1 notes restricted stock awards totaling 38,660 shares (the filing indicates restricted awards but does not further detail vesting here).
  • Filing timeliness: Filed within one business day of the transaction (not late).

Context
Restricted stock awards are typically compensation that vests over time and are not immediate cash sales; a $0 grant price is common for such awards. Awards are different from open-market purchases or sales and do not directly signal an immediate change in trading behavior.